Home > NewsRelease > CBD Company Perspectives on FDA Policy Outlook
Text
CBD Company Perspectives on FDA Policy Outlook
From:
Mr. Pulak Sharma & Dr. Priyanka Sharma -- Kazmira -- Premier Science -- Premier CBD Products Mr. Pulak Sharma & Dr. Priyanka Sharma -- Kazmira -- Premier Science -- Premier CBD Products
For Immediate Release:
Dateline: Watkins , CO
Wednesday, July 15, 2020

 

Co-CEO Mr. Pulak Sharma will be joining Cowen Inc. representing CBD manufacturers along with CV Sciences and Charlotte’s Web for a panel discussion entitled ‘CBD Company Perspectives on FDA Outlook.’

The Cowen Virtual Presentation Series, 2020 Cannabis Policy Summit, will take place on Thursday, July 16th, beginning at 12 PM ET. The panel for CBD Company Perspectives on FDA Outlook is scheduled from 3:45 PM – 4:30 PM ET

Request registration for this event here: https://www.meetmax.com/sched/event_65449/conference_home.html?bank_access=0&event_id=65449

News Media Interview Contact
Name: Pulak Sharma
Title: CEO
Group: Kazmira LLC
Dateline: Watkins, CO United States
Direct Phone: 720-531-1634
Jump To Mr. Pulak Sharma & Dr. Priyanka Sharma -- Kazmira -- Premier Science -- Premier CBD Products Jump To Mr. Pulak Sharma & Dr. Priyanka Sharma -- Kazmira -- Premier Science -- Premier CBD Products
Contact Click to Contact